Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Newbury Pharmaceuticals

Market Cap: SEK 81.3m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Camurus

Market Cap: SEK 31.9b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

Vitrolife

Market Cap: SEK 20.6b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Devyser Diagnostics

Market Cap: SEK 1.4b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

AstraZeneca

Market Cap: SEK 155.2b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Biotage

Market Cap: SEK 7.0b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

Swedish Orphan Biovitrum

Market Cap: SEK 87.3b

An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Biovica International

Market Cap: SEK 68.5m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.

Saniona

Market Cap: SEK 756.2m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.

NextCell Pharma

Market Cap: SEK 78.2m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

AroCell

Market Cap: SEK 129.0m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

BICO Group

Market Cap: SEK 2.5b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

MedCap

Market Cap: SEK 5.4b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Sprint Bioscience

Market Cap: SEK 44.8m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Corline Biomedical

Market Cap: SEK 211.6m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Orexo

Market Cap: SEK 483.1m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally.

AcouSort

Market Cap: SEK 56.0m

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.

Xbrane Biopharma

Market Cap: SEK 301.8m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Bonesupport Holding

Market Cap: SEK 19.2b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

SenzaGen

Market Cap: SEK 128.9m

Provides non-animal tests for assessing a substance’s allergenicity.

BioArctic

Market Cap: SEK 14.6b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

Oncopeptides

Market Cap: SEK 441.1m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.